Yttrium (90Y) tacatuzumab tetraxetan: Difference between revisions
Appearance
Content deleted Content added
No ChemSpider ID for this record |
Updating {{drugbox}} (changes to verified fields - updated 'ChemSpiderID_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref') per Chem/Drugbox validation (report [[Wikipedia talk:WikiProject_... |
||
Line 1: | Line 1: | ||
{{DISPLAYTITLE:Yttrium (<sup>90</sup>Y) tacatuzumab tetraxetan}} |
{{DISPLAYTITLE:Yttrium (<sup>90</sup>Y) tacatuzumab tetraxetan}} |
||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = changed |
|||
| verifiedrevid = 450331860 |
| verifiedrevid = 450331860 |
||
| image = Y-90 tacatuzumab tetraxetan structure.svg |
| image = Y-90 tacatuzumab tetraxetan structure.svg |
||
Line 31: | Line 32: | ||
<!--Identifiers--> |
<!--Identifiers--> |
||
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|||
| ChemSpiderID = NA |
| ChemSpiderID = NA |
||
| CAS_number_Ref = {{cascite|correct|??}} |
| CAS_number_Ref = {{cascite|correct|??}} |
Revision as of 23:41, 13 November 2011
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Humanized (from mouse) |
Target | α-fetoprotein |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider | |
Chemical and physical data | |
Formula | C6470H9971N1712O2007S4290Y |
Molar mass | 145 kDa |
|
Yttrium (90Y) tacatuzumab tetraxetan (trade name AFP-Cide) is a humanized monoclonal antibody intended for the treatment of cancer.[1] The antibody itself, tacatuzumab, is conjugated with tetraxetan, a chelator for yttrium-90[2], a radioisotope which destroys the tumour cells.
References